288392-69-8
288392-69-8
Chemical Structure
Siplizumab
Synonym(s): MEDI-507; TCD601
- CAS No.: 288392-69-8
- Formula:N/A
- Molecular Weight:(146.25 kDa)
IUPAC Name: 4-(2-((E)-2-((E)-2-chloro-3-((Z)-2-(1-(4-sulfobutyl)benzo[cd]indol-2(1H)-ylidene)ethylidene)cyclohex-1-en-1-yl)vinyl)benzo[cd]indol-1-ium-1-yl)butane-1-sulfonate
SMILES: [Siplizumab]
Biological Activity: Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Siplizumab | 99.83% | Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
